Nobutaka Nishimura

Probiotics enhances anti‐tumor immune response induced by gemcitabine plus cisplatin chemotherapy for urothelial cancer

Makito Miyake, Yuki Oda, Takuya Owari et al. · Cancer Science · 2022 · 41 citations · Full text

Enfortumab vedotin following platinum-based chemotherapy and immune checkpoint inhibitors for advanced urothelial carcinoma: response, survival and safety analysis from a multicentre real-world Japanese cohort

Makito Miyake, Nobutaka Nishimura, Yuki Oda et al. · Japanese Journal of Clinical Oncology · 2023 · 34 citations

Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method

Makito Miyake, Nobutaka Nishimura, Yasushi Nakai et al. · Diagnostics · 2021 · 27 citations · Full text

Switch-maintenance avelumab immunotherapy following first-line chemotherapy for patients with advanced, unresectable or metastatic urothelial carcinoma: the first Japanese real-world evidence from a multicenter study

Makito Miyake, Takuto Shimizu, Yuki Oda et al. · Japanese Journal of Clinical Oncology · 2022 · 20 citations

Tumor expression of Nectin-1–4 and its clinical implication in muscle invasive bladder cancer: An intra-patient variability of Nectin-4 expression

Makito Miyake, Tatsuki Miyamoto, Takuto Shimizu et al. · Pathology - Research and Practice · 2022 · 18 citations

Tumor Biology, Urology, Oncology +10